New monoclonal antibody provides full protection against malaria parasite 🦠🛡️: In new double-blind, placebo-controlled trial, people were exposed to mosquitos 🦟 carrying malaria, several months after dosing. None who received highest dose of antibody developed infection, compared to all in placebo group.

Read Full Article

#MalariaResearch #MonoclonalAntibodies #PublicHealth #ClinicalTrials #VaccineInnovation

Stem Cell Infusion 🧬 Reduces Heart Failure ❤️‍🩹 After Heart Attack 💔 in Phase 3 Trial 📊

Read Full Article

#StemCellTherapy #HeartHealth #HeartFailure #ClinicalTrials #MedicalInnovation

Early-stage clinical trial demonstrates promise of intranasal influenza vaccine in generating broad immunity against multiple strains of H5N1 “bird flu" 🦠💉🌍. This trial shows that this intranasal, shelf-stable H5N1 vaccine could play a major role in pandemic preparedness.

Read Full Article

#InfluenzaVaccine #H5N1 #PandemicPreparedness #ClinicalTrials #PublicHealth

Phase I/II trial of AMT-130 gene therapy for Huntington’s disease reports slowed disease progression versus natural history cohort 🧬🧠📉

Read Full Article

#HuntingtonsDisease #GeneTherapy #AMT130 #ClinicalTrials #HealthInnovation

A new cholesterol-lowering pill shows promise in clinical trials 💊📈

Read Full Article

#Cholesterol #HealthInnovation #ClinicalTrials #HeartHealth #Wellness

Study finds recent NIH cuts by Trump administration have halted 383 clinical trials, affecting over 74,000 enrolled patients; trials impacted include infectious diseases 🦠, heart disease ❤️, and cancer treatments 🎗️.

Read Full Article

#NIHcuts #ClinicalTrials #PublicHealth #CancerResearch #InfectiousDiseases

Continuous cough monitoring accurately quantifies disease burden and day-to-day variability, enabling earlier detection of patient deterioration, more sensitive clinical trial endpoints, and population-level disease surveillance 📊💉🩺🌍

Read Full Article

#CoughMonitoring #HealthTech #PatientCare #ClinicalTrials #DiseaseSurveillance

First-in-human clinical trial of personalized, biomaterial-based cancer vaccine demonstrates feasibility, safety, and immune activation 💉🧬✨

Read Full Article

#CancerResearch #PersonalizedMedicine #ClinicalTrials #Immunotherapy #Biomaterials

Review of multitude of preclinical and clinical studies support the repurposing of atomoxetine for Alzheimer's Disease (AD) drug development for both symptoms and neuroprotection to slow disease progression 🧠💊📈

Read Full Article

#AlzheimersResearch #Atomoxetine #DrugRepurposing #Neuroprotection #ClinicalTrials

Effect of ‘gamechanger’ Alzheimer’s drugs ‘trivial’, review concludes. Data assessed from 17 clinical trials of anti-amyloid drugs found no ‘meaningful effect’ on cognitive decline.

Read Full Article

#Alzheimers #Dementia #ClinicalTrials

Trials of psychedelics for mental health may be invalid, because it's fairly obvious to patients whether they've been given a psychedelic or a placebo. Blinding failed more than 90% of the time in the studies of psilocybin, LSD and DMT, and 85% of the time in studies of MDMA.

Read Full Article

#Psychedelics #MentalHealth #ClinicalTrials

Asundexian for Secondary Stroke Prevention (Masjuan, et al., 2026)

Read Full Article

#Stroke #StrokePrevention #ClinicalTrials

🍄 A single dose of psilocybin shows promise as a treatment for cocaine addiction, with study participants more likely to abstain from cocaine compared to those who received a placebo. The study, published in Jama Network Open, involved 19 participants receiving psilocybin and 17 receiving a placebo, with both groups supported by a therapist.

🧠 Experts suggest psilocybin may work by increasing neuroplasticity and psychological plasticity, aiding in changing rigid, impulsive behaviors associated with addiction. Unlike some other addiction medications, psilocybin creates a profound altered state of consciousness within a single therapy session, acting as a catalyst for change rather than a daily medication.

⚖️ This trial is also significant for being the first psychedelic clinical trial to include a majority of Black participants, addressing a gap in representation within current psychedelic research, which often attracts more affluent and white individuals.

#PsychedelicTherapy #AddictionTreatment #ClinicalTrials

🧠 A new clinical study is evaluating Vortioxetine, an antidepressant, as a potential treatment for newly diagnosed glioblastoma, an aggressive brain tumor with limited treatment options.

🔬 The ReVoGlio study aims to see if Vortioxetine, given alongside standard treatments (surgery, radiation, chemotherapy), can extend progression-free survival and improve patients' quality of life.

🌍 This trial is authorized by the Ethics Committee Zurich on May 19, 2026, and will take place at trial sites in Aarau, Basel, Luzern, St. Gallen, and Zurich.

#Glioblastoma #CancerResearch #ClinicalTrials

🔥 ABRUPT2 Trial Results: Albumin Boosts Burn Resuscitation

• The ABRUPT2 study, a large-scale trial involving 99 patients with severe burns (mean 46% TBSA), compared lactated Ringer's (LR) alone versus LR with 5% albumin for fluid resuscitation.

• While the study was stopped early due to low enrollment, data showed that patients receiving albumin required significantly less fluid in the first 24 and 48 hours compared to those receiving LR alone.

• Specifically, the LR group received 1.5 to 2.1 times more fluid resuscitation at 24 and 48 hours, respectively, than the albumin group. Notably, 51% of LR patients switched to albumin, with no reverse crossovers.

• Importantly, no significant differences were observed in mortality, healing time, or acute kidney injury between the groups.

#BurnCare #MedicalResearch #ClinicalTrials

❤️ World-first trial reveals cholesterol-lowering statin medication significantly reduces heart attack/stroke risk for people over 70.

📊 The decade-long, randomized control trial involved nearly 10,000 participants aged 70+ and found a 30% decrease in first major cardiovascular events.

💡 For every 37 older adults treated with daily statins, one major cardiac event (heart attack, stroke, or heart surgery) could be prevented.

🧠 The study also found no significant increase in dementia rates among statin users, addressing a common concern.

#Statins #HeartHealth #ClinicalTrials

✨ New study in JAMA Dermatology reveals promising results for upadacitinib in treating severe alopecia areata.

📈 Two Phase 3 clinical trials involving 1,399 participants (aged 12-64, including 118 adolescents) showed significant hair regrowth. Around 45-55% of participants on upadacitinib achieved an 80% scalp hair coverage within 24 weeks, compared to 1.5-3.4% on placebo.

👩‍⚕️ The drug, upadacitinib, demonstrated a positive benefit-risk profile, with early differentiation from placebo observed as early as week 8. Participants also reported improvements in quality of life.

⚠️ Limitations include the 24-week trial duration and that the trials were funded and co-designed by AbbVie, the manufacturer of upadacitinib. Further testing is needed.

#AlopeciaAreata #HairLoss #ClinicalTrials

New candidate to treat progressive supranuclear palsy (PSP) reports positive phase2a results and warrants future clinical trials

Read Full Article

#PSP #NeurodegenerativeDisease #ClinicalTrials

Simpler clinical trials can safely fast-track new treatments for severe bladder cancer. For patients too weak to have their bladder removed, experts agree these streamlined studies are an ethical alternative to traditional randomized testing

Read Full Article

#BladderCancer #ClinicalTrials #CancerResearch

Retatrutide, a triple hormone receptor agonist, for treatment of obesity | TRIUMPH-1 phase 3 clinical trial results show average patient lost 30% of body weight at 104 weeks on highest dose

Read Full Article

#ObesityTreatment #ClinicalTrials #WeightLoss2024